Skip Navigation Archive: U.S. Department of Health and Human Services U.S. Department of Health and Human Services
Archive: Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home—Live Site | Archive Home | Site Map
Archival print banner

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to www.ahrq.gov for current information.

29. HHS Guidance on PSOs and FDA Reporting

Director's Update

Text version of slide presentation from a National Advisory Council meeting.

Text Description is below the image.

  • The Guidance:
    • Permits all mandatory reporting to the FDA [Food and Drug Administration] as required by Federal law or regulation.
    • Allows FDA to inspect the facilities of PSOs [Patient Safety Organizations] with FDA mandatory reporting obligations.
    • Permits FDA to use the information obtained from its inspections to carry out its enforcement responsibilities.
    • States that a PSO that does not meet these obligations would be creating a conflict of interest and can be delisted by AHRQ.

 

Previous Slide         Contents         Next Slide

Page last reviewed August 2011
Page originally created August 2011
Internet Citation: 29. HHS Guidance on PSOs and FDA Reporting. Content last reviewed August 2011. Agency for Healthcare Research and Quality, Rockville, MD. https://archive.ahrq.gov/news/events/nac/2011-04-nac/clancy/slide29.html

 

The information on this page is archived and provided for reference purposes only.

 
AHRQ Advancing Excellence in Health Care